Literature DB >> 18241740

Fluoroquinolone resistance in pediatric bloodstream infections because of Escherichia coli and Klebsiella species.

Jason Y Kim1, Ebbing Lautenbach, Jaclyn Chu, Monika Goyal, Irving Nachamkin, Karin McGowan, Susan Coffin, Theoklis Zaoutis.   

Abstract

In pediatric bloodstream infections with fluoroquinolone (FQ)-resistant Escherichia coli and Klebsielia species, we noted an association between FQ resistance and extended-spectrum beta-lactamase (ESBL) production (OR, 12; 95% CI: 2.28-83.8). A case control study revealed no significant risk factors (including prior antibiotic use) for FQ resistance among ESBL E coli and Klebsiella species (ESBL-EK).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18241740     DOI: 10.1016/j.ajic.2007.01.012

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  5 in total

1.  Resistance against broad-spectrum beta-lactams among uropathogens in children.

Authors:  Maria Bitsori; Sofia Maraki; Maria Kalmanti; Emmanouil Galanakis
Journal:  Pediatr Nephrol       Date:  2009-07-28       Impact factor: 3.714

Review 2.  Safety Concerns Surrounding Quinolone Use in Children.

Authors:  Karisma Patel; Jennifer L Goldman
Journal:  J Clin Pharmacol       Date:  2016-03-28       Impact factor: 3.126

Review 3.  Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Authors:  A Dalhoff
Journal:  Infection       Date:  2012-03-30       Impact factor: 3.553

4.  Genomic insights into the circulation of pandemic fluoroquinolone-resistant extra-intestinal pathogenic Escherichia coli ST1193 in Vietnam.

Authors:  Quynh Nguyen; To Thi Nguyen Nguyen; Phuong Pham; Vinh Chau; Lan Phu Huong Nguyen; Toan Duc Nguyen; Tuyen Thanh Ha; Nhi Thi Quynh Le; Duong Thuy Vu; Stephen Baker; Guy E Thwaites; Maia A Rabaa; Duy Thanh Pham
Journal:  Microb Genom       Date:  2021-12

5.  Global fluoroquinolone resistance epidemiology and implictions for clinical use.

Authors:  Axel Dalhoff
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.